We have located links that may give you full text access.
Journal Article
Review
Anti-TNF therapy in inflammatory bowel diseases: a huge review.
Minerva Gastroenterologica e Dietologica 2010 June
Anti-tumour necrosis factor-alpha (TNF-a) agents have changed the way of treating inflammatory bowel diseases (IBD) refractory to conventional medications (corticosteroids, immu-nomodulators). Infliximab, adalimumab, and certolizumab are more effective than placebo for induction and maintenance of remission in luminal Crohn's disease. Infliximab and adalimumab are also effective for maintenance of fistula closure in Crohn's disease. Only infliximab is Food and Drug Administration (FDA)-approved for ulcerative colitis. Only adalimumab has demonstrated its efficacy in a randomized controlled trial to induce remission after infliximab failure in Crohn's disease. Anti-TNF therapy leads to mucosal healing, reduces hospitalizations and surgeries, and improves patients' quality of life. Safety data indicate that serious infections occur in 2-4% of patients treated with anti-TNF therapy, with no statistical difference when compared to controls. The risk of rare events such as malignancies and lymphoma, in IBD patients treated with anti-TNF agents, will require a longer duration of follow-up. Currently, the risk-benefit ratio of anti-TNF therapy supports its use in IBD. Several questions remain to be answered: can an indiscriminate use of anti-TNF agents modify the natural course of the disease, should mucosal healing be used in clinical practice, and should anti-TNF therapy be used alone or in combination with immunomodulators in the long-term?
Full text links
Related Resources
Trending Papers
Revascularization Strategy in Myocardial Infarction with Multivessel Disease.Journal of Clinical Medicine 2024 March 27
Intravenous infusion of dexmedetomidine during the surgery to prevent postoperative delirium and postoperative cognitive dysfunction undergoing non-cardiac surgery: a meta-analysis of randomized controlled trials.European Journal of Medical Research 2024 April 19
The Tricuspid Valve: A Review of Pathology, Imaging, and Current Treatment Options: A Scientific Statement From the American Heart Association.Circulation 2024 April 26
Consensus Statement on Vitamin D Status Assessment and Supplementation: Whys, Whens, and Hows.Endocrine Reviews 2024 April 28
Management of Diverticulitis: A Review.JAMA Surgery 2024 April 18
Interstitial Lung Disease: A Review.JAMA 2024 April 23
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app